Back

Amyloid progression or comorbidities? Differentiating management for optimal outcomes

31 August 2025 (13:05 - 13:20)
Organised by: Logo
Congress Presentation Part of: Setting the bar at survival: clinical decision-making in an evolving ATTR-CM landscape Cardiac Amyloidosis Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Marianna Fontana

University College London, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Evolving the understanding of TTR's role in health and disease​
Doctor P. Garcia-Pavia (Majadahonda, ES)
Slides
Presentation thumbnail
Exploring the wealth of long-term data for ATTR-CM management​
Professor T. Damy (Creteil, FR)
Slides
Presentation thumbnail
Q&A
Professor M. Fontana (London, GB) Doctor P. Garcia-Pavia (Majadahonda, ES) Professor T. Damy (Creteil, FR)

Access the full session

Session thumbnail
Setting the bar at survival: clinical decision-making in an evolving ATTR-CM landscape
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 13:05 CET
You may be interested in
thumbnail
Congress Session
Clinical and real-world data in ATTR cardiomyopathy: reviewing their place in daily practice
19 May 2025
thumbnail
Webinar
The role of cardiac imaging for assessment of specific patient populations, according to new 2022 ESC Guidelines on Cardio-Oncology.
13 January 2023
thumbnail
Congress Presentation
Cardiac transthyretin wild-type amyloidosis (ATTRwt): a prospective study of 400 patients followed at the Italian referral center.
28 August 2020
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources